Classer les publications sur l'année
-
Santé publique
PrĂ©vac B: prĂ©vention de l’hĂ©patite B dans les populations migrantes originaires de zones de forte endĂ©mie, Afrique subsaharienne et Asie
AUBERT JP, CATRICE M, BOUEE S, DI PUMPO A, SANTANA P, GERVAIS A, WAJSBROT A, GELLY J, NOUGAIREDE M
Revue du Praticien (supplément) ; 2010;60:13-20
-
Pharmaco-Epidémiologie
Neodymium : YAG laser rates after bilateral implantation of hydrophobic or hydrophilic multifocal intraoculenses : twenty-four month retrospective comparative study
GAUTHIER L, LAFUMA A, LAURENDEAU C, BERDEAUX G
J Cataract Refract Surg ; 2010;36(7):1195-1200
-
Ăconomie de la santĂ©
Modelling the budget impact of Darunavir in the treatment of highly treatment-experienced, HIV-Infected adults in France
COLIN X, LAFUMA A, COSTAGLIOLA D, SMETS E, MAUSKOPF J, GUILLON P
Pharmacoeconomics ; 2010;28(S1):183-197
-
Pharmaco-Epidémiologie
Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control : a survey
NORDMANN JP, BAUDOUIN C, RENARD JP, DENIS P, LAFUMA A, LAURENDEAU C, JEANBAT V, BERDEAUX G
Clin Ophtalmol ; 2010;4:731-739
-
Ăconomie de la santĂ©
Lifetime costs and effectiveness of ReSTOR compared with a monofocal IOL and Array-SA40 in the Netherlands
DE VRIES NE, LAURENDEAU C, LAFUMA A, BERDEAUX G, NUIJTS RM
Eye ; 2010;24(4):663-672
-
Ăconomie de la santĂ©
Inpatient costs of endophthalmitis evaluated for the whole of France
COLIN X, BERDEAUX G, LAFUMA A, SALVANET-BOUCHARA A, KODJIKIAN L
Appl Health Econ Health Policy ; 2010;8(1):53-60
-
Ăconomie de la santĂ©
In-patient care costs of patients with bipolar I disorder : a comparison between two European centers
GONZALEZ-PINTO AM, DARDENNES R, DE ZELICOURT M, LOPEZ P, OLIVEROS RG, VIETA E, BARBEITO S, ECHEVARRIA E, FAGNANI F
J Affect Disord ; 2010;121(1-2):152-155
-
Pharmaco-Epidémiologie
Infliximab Paediatric Crohn’s Disease Educational Plan : A European, Cross-Sectional, Multicentre Evaluation
ARANA A, ALLEN S, BURKOWITZ J, FANTONI V, GHATNEKAR O, RICO MT, VANHAVERBEKE N, WENTWORTH CE, BROSA M, ARELLANO F
Drug Saf ; 2010;33(6):489-501
-
Santé publique
Evaluation de réseaux de santé en diabétologie
DETOURNAY B, BOUEE S, DONIO V, GADENNE S, COUROUVE L
Qual Saf Health Care ; 2010;19(1):161-162
-
Santé publique
Efficacy of moxifloxacin in treating bacterial conjunctivitis : a meta-analysis
KODJIKIAN L, LAFUMA A, KHOSHNOOD B, LAURENDEAU C, BERDEAUX G
J Fr Ophtalmol ; 2010;33(4):227-233
-
Pharmaco-Epidémiologie
DiabĂšte de type 2 : pratiques d’intensification thĂ©rapeutique chez les mĂ©decins gĂ©nĂ©ralistes en France en 2008-2009
BOUEE S, DETOURNAY B, BALKAU B, BLICKE JF, AVIGNON A, ATTALI C, HALIMI S
BEH ; 2010;42-43:436-440
-
Pharmaco-Epidémiologie
Characteristics and management of outpatients with history of or current atrial fibrillation : the observational French EPHA study
COHEN A, DALLONGEVILLE J, DURAND-ZALESKI I, BOUĂE S, LE HEUZEY JY, the EPHA Investigators
Arch Cardiovasc Dis ; 2010;103(6-7):376-387
-
Ăconomie de la santĂ©
Analyse économique des soins des personnes traitées pour diabÚte (études Entred 2001 et 2007)
RICCI P, CHANTRY M, DETOURNAY B, POUTIGNAT N, KUSNIK-JOINVILLE O, RAIMOND V, THAMMAVONG N, WEILL A
Pratiques et Organisation des soins ; 2010;41(1):1-10
-
Ăconomie de la santĂ©
Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol,bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma : an analysis based on the United Kingdom general practitioner research database
LAFUMA A, SALMON JF, ROBERT J, BERDEAUX G
Clin Ophtalmol ; 2011;5:361-370
-
Ăconomie de la santĂ©
Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study
ARMOIRY X, FAGNANI F, BENBOUBKER L, FACON T, FERMAND JP, HULIN C, MOREAU P, AULAGNER G
J Clin Pharm Ther ; 2011;36(1):19-26